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Background: Age-related white matter changes
(ARWMCs), frequently detected on neuroimaging, are
associated withmotor, cognitive, urinary, andmood dis-
orders. The LADIS (LeukoAraiosis and DISability) Study
primarily aims to assess ARWMCs as a determinant of
global functional decline in the elderly population.
Methods:Weenrolled 639 patients (mean age, 74.1±5.0
years; 45.1% male) referred for nondisabling com-
plaints, who had ARWMCs detected on brain magnetic
resonance imaging (MRI) of mild, moderate, or severe
grade according to the Fazekas scale. At the 1-year follow-
up, 619 were reassessed using the Instrumental Activi-
ties of Daily Living (IADL) scale. Of these, 506 were to-
tally independent at baseline, and 113 were impaired in
only 1 item of the IADL scale.We studied the 1-year tran-
sition to 2 or more activities limited and selective func-
tional impairments as cofactors of functional decline.
Results: The rate of transition was 9%, 15%, and 26%,
in the mild, moderate, and severe ARWMC group, re-
spectively. Comparing the severe with themild ARWMC
groups and adjusting for age and for other predictors of
decline, the risk was more than 2-fold higher (odds ra-
tio; 2.38; 95% confidence interval, 1.29-4.38) in pa-
tients with 0 or 1 activity limited, and 3-fold higher (odds
ratio, 3.02; 95% confidence interval, 1.34-6.78) among
patients fully independent at baseline. Both motor and
cognitive deterioration predominantly explained the ef-
fect of ARWMCs on global functional decline.
Conclusion: Elderly patients who are functionally in-
dependent and who have severe ARWMCs are at con-
siderable risk of becomingmore dependent in a short pe-
riod, mostly owing tomotor and cognitive deterioration.
Arch Intern Med. 2007;167:81-88
M ANY OLDER PEOPLEwithout major neuro-logical diseases havehyperintensities in thewhite matter on brain
magnetic resonance imaging (MRI), also
called leukoaraiosis or age-related white
matter changes (ARWMCs).1 In about one
third of cases, these changes are of mod-
erate to severe grade.2
Functional problems such as walking
difficulties, cognitive impairment, depres-
sion, and urinary incontinence are all com-
mon among elderly people. These are the
deficits contributing themost to loss of in-
dependence in everyday life activities and
have been consistently reported to be as-
sociated with ARWMCs.3 Transition from
autonomous daily living to dependence on
others is a crucial event in the personal,
family, and social life of an elderly per-
son. Age-related disability is a social and
economic challenge that all modern soci-
eties are facing.
TheLADIS (LeukoAraiosis andDISabil-
ity) Study is amulticenter collaborationpri-
marily aimedat investigating, througha lon-
gitudinal design,whether ARWMCs are an
independent determinant of global func-
tional decline in the elderly population.4
In this article, we report on global func-
tional decline occurring 1 year after the ini-
tial assessment in a cohort of older pa-
tients, who, while being evaluated for
nondisabling problems, underwent brain
MRI and report howmuch the decline de-
pended on ARWMCs.
METHODS
The rationale of the LADIS Study are fully de-
scribed elsewhere.4 In short, the facts that preva-
Author Affiliations are listed at
the end of this article.
Group Information:
Participating centers and
personnel in the LADIS Study
are listed on page 87.
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lence and severity of ARWMCs increase with age and that sev-
eral dysfunctions occurring with age and contributing toward
functional disability have been reported as being associatedwith
ARWMCs5 have raised the hypothesis that these changesmay be
one of the age-related disease processes involved in the disabil-
ity transition in the elderly population, independent of other pos-
sible determinants of disability. Another unsolved issue is what
grade of ARWMCs is able to produce clinical effects. Prespeci-
fied objectives of the LADIS Study included the following: (1) to
establish whether ARWMCs and their progression play a role as
an independent determinant of the transition from functional au-
tonomy to disability in elderly subjects; (2) to confirm whether
ARWMCs and their progression predict death from any cause or
specific causes, dementia, cardiovascular events, and depres-
sion; (3) to examine whether progression of ARWMCs parallels
the deterioration of motor and cognitive performances; and (4)
to evaluate the impact of ARWMCs on quality of life. According
to the activities in the InstrumentalActivity ofDailyLiving (IADL)
scale used by Lawton and Brody,6 the primary end point was the
transition from 0 or 1 activity limited at baseline to 2 ormore ac-
tivities limited at follow-up. This corresponds with the transi-
tion from no or mild to moderate or severe disability and is the
categorization used by longitudinal, population-based studies of
disability conducted in similarly aged cohorts.7-9 The risks esti-
mated by these studies of such transition in the general popula-
tion were used to estimate the power and sample size of our
project.4
PARTICIPANTS
The study population comprised patients aged between 65 and
84 years, who, while being investigated for complaints such as
mildmemory ormotor problems,minor cerebrovascular events,
mood alterations, or otherminor neurological problems (all not
interfering with daily life activities), exhibited ARWMCs of any
degree on brainMRI at 1 of the 11 collaborating European cen-
ters. Subjects in whomARWMCswere incidentally foundwere
also considered. Patients had to performwithout help in all the
activities of the IADL scale or to be impaired on just 1 activity.
Other inclusion criteria were signed informed consent and hav-
ing a regularly contactable informant. Reasons for exclusion
were (1) severe illnesses (cardiac, hepatic, or renal failure; can-
cer; or other relevant systemic diseases); (2) unrelated severe
neurological diseases; (3) leukoencephalopathy of nonvascu-
lar origin (immunologic, demyelinating, metabolic, toxic, in-
fectious, or other); and (4) severe psychiatric disorders.
ASSESSMENT
Subjects were assessed at baseline using a protocol that in-
cluded a detailed MRI study and several functional and clini-
cal measures.4 After enrollment, subjects had yearly clinical and
functional reassessments. At entry and at each follow-up, pa-
tients were administered a structured questionnaire to assess,
among other variables, education (expressed as years of school-
ing), living conditions (alone or with others), history of myo-
cardial infarction and/or angina pectoris (ischemic heart dis-
ease), stroke, heart failure, arrhythmias, arterial hypertension,
peripheral vascular disease, diabetes mellitus, chronic obstruc-
tive pulmonary disease, depression, gait disturbances, osteoar-
thritis, falls in the last year, visual impairment, hearing loss,
and hospital admissions. The definition of each variable was
based on updated criteria.4 All the patients had a standard physi-
cal examination, duringwhich bodymass index and pulse pres-
sure were also registered.
The IADL scale includes 8 activities: ability to use the tele-
phone, shopping, foodpreparation, housekeeping, laundry,mode
of transportation, responsibilities for ownmedications, and abil-
ity to handle finances. In the IADL questionnaire, depending on
the type of task, questions are asked as to whether the task is
accomplishedwithout any limitation or with difficulties or help
is needed. The study outcomewas the limitation of any type (ei-
ther difficulty or need of help) presented by the subject in more
than 1 activity. The IADL scale was administered from baseline
only to the informant because of the expectation of cognitive de-
cline at follow-up. A test of the interrater, intercenter reliability
of IADL scoring, performed using descriptions of the perfor-
mance translated into English, showed good agreement in rat-
ings of each scale item ( statistic ranging from 0.69 to 0.85). A
comprehensive test battery was used to assess global and se-
lected cognitive domains.4 Of these tests, for the purposes of the
present study, ie, determining which functional domains (cog-
nitive, motor, mood, or sphincteral) contributed themost to the
possible prediction by degree of ARWMCs with respect to glo-
bal functional decline, we used the results of the Alzheimer Dis-
ease Assessment Scale (ADAS)10 and those of the 15-item Geri-
atricDepression Scale (GDS-15)11 for the cognitive and themood
domain, respectively. Verification of the intercenter agreement
on these tests was considered unfair, given the lists of words and
questions specifically validated in individual countries. Changes
in motor performance were assessed using a modified version
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Figure 1. Age-related white matter changes: the 3 severity degrees
according to the modified scale by Fazekas et al.13 Grade 1, mild (A), grade 2,
moderate (B), and grade 3, severe (C) white matter changes.
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of the Short Physical Performance Battery (SPPB).12 We also re-
corded the occurrence of urinary dysfunction (defined as com-
plaints of nocturia, urinary frequency, urgency, or inconti-
nence) during the follow-up period.
Baseline ARWMC severity was rated centrally by 1 rater who
was blind to the clinical and functional data, using the visual
Fazekas scale.13 Accordingly, patients were subdivided into 3
severity groups: grade 1, mild ARWMCs (single lesions 10
mm; areas of “grouped” lesions20mm in any diameter); grade
2, moderate ARWMCs (single hyperintense lesions between 10
to 20 mm; areas of “grouped” lesions 20 mm in any diam-
eter; nomore than “connecting bridges” between individual le-
sions); and grade 3, severe ARWMCs (single lesions or con-
fluent areas of hyperintensity 20 mm in any diameter)
(Figure 1).
We reportherein the attainmentof theprimary studyendpoint
(transition to2 IADL activities limited) at 1-year follow-up in
the target LADIS population (patients with both 0 and 1 IADL
activity limited) and among patients who were fully indepen-
dent (0 activities limited) at baseline IADL assessment.
STATISTICAL ANALYSIS
In the 619 patients reassessed at the 1-year follow-up, we first
examined baseline demographics, risk factors, and comorbid
conditions across the 3 ARWMCs severity groups. This was
done in a univariate fashion. The net predictive effect of
ARWMC severity on the primary study end point, comparing,
as preplanned, the severe and moderate groups with the mild
one taken as reference,4 was analyzed using multiple logistic
regression analysis (forward stepwise method), controlling
for the several baseline factors listed in the assessment sec-
tion. These were the factors reported as the best predictors of
global functional decline in the elderly as evidenced by the
meta-analysis by Stuck et al.14
By furthermultiple regression analysis, we evaluatedwhether
acute events occurring during the 1-year follow-up influenced
the disability transition. In thismodel, we entered, togetherwith
age and ARWMC severity, living conditions, falls, incidental
stroke or myocardial infarction, heart failure, and hospitaliza-
tion resulting from the 1-year assessment, each of which were
studied as a possible confounder of the transition.
To explore which of the dysfunctions (cognitive, motor,
mood, or urinary) had the greatest contribution to
ARWMC-related functional decline, changes in theADAS, SPPB,
and GDS scores and incident urinary dysfunction were en-
tered as covariates in a logistic regressionmodel, with ARWMCs
and age as predictors of the primary study end point. If any of
these variables reduced the odds ratio (OR) expressing the
amount of the effect of ARWMCs on transition, this was taken
as evidence that deterioration in that domain was involved in
the prediction of decline by ARWMC severity.
RESULTS
Of the 639 patients (mean±SD age, 74.1±5.0 years; 45.1%
male) enrolled, 619 (96.9%) (mean±SD age, 74.1±5.1
years, 45.1% male) had their IADL status reassessed at
the 1-year follow-up. At entry, 506 of these patients were
independent in every IADL activity and 113 were im-
paired in just 1 activity. Among the 619 subjects reex-
amined at 1-year follow-up, the distribution of baseline
ARWMC severity was as follows: 44% mild, 31% mod-
erate, and 25% severe. Male sex, older age group, his-
tory of arterial hypertension, stroke, heart failure, falls
Table 1. Baseline Demographics, Risk Factors, and Comorbid Conditions Across Patients With Different ARWMC Severity
Variable
ARWMC Severity
Total Sample*
(n = 619; 100%)
Moderate
vs Mild† Severe vs Mild†
Mild*
(n = 278; 44.9%)
Moderate*
(n = 192; 31.0%)
Severe*
(n = 149; 24.1%)
Sex (male) 44.2 39.1 54.4 45.1 0.81 (0.56-1.17) 1.50 (1.01-2.24)
Age 75 y 36.3 46.9 52.3 43.5 1.55 (1.06-2.25) 1.92 (1.29-2.88)
Living condition (with others) 62.2 55.7 68.5 61.7 0.76 (0.53-1.11) 1.32 (0.86-2.01)
Ischemic heart disease 20.3 20.8 18.2 20.0 1.02 (0.66-1.63) 0.88 (0.53-1.46)
Heart failure 2.2 2.6 6.1 3.2 1.21 (0.36-4.01) 2.92 (1.02-8.38)
Arterial hypertension 63.5 74.0 77.0 70.0 1.63 (1.09-2.44) 1.92 (1.22-3.03)
Atrial fibrillation 6.9 6.3 9.5 7.3 0.91 (0.43-1.92) 1.42 (0.69-2.92)
Diabetes 12.2 12.6 17.1 13.5 1.03 (0.59-1.80) 1.48 (0.85-2.60)
Depression 27.3 29.7 26.2 27.8 1.12 (0.75-1.68) 0.94 (0.60-1.48)
Falls in the last year 23.7 29.3 34.9 28.2 1.33 (0.88-2.02) 1.72 (1.11-2.66)
Osteoarthritis 31.0 27.7 24.3 28.4 0.85 (0.57-1.28) 0.71 (0.45-1.12)
History of stroke 16.9 30.9 47.7 28.6 2.20 (1.42-3.41) 4.47 (2.85-7.01)
Chronic obstructive pulmonary
disease
9.7 9.4 12.8 10.4 0.97 (0.52-1.81) 1.36 (0.73-2.54)
Complaint of gait disturbances 37.8 36.3 51.7 40.7 0.94 (0.64-1.37) 1.76 (1.17-2.64)
Urinary disturbances 39.2 34.4 49.7 40.2 0.81 (0.55-1.19) 1.53 (1.02-2.28)
Visual impairment 13.3 17.7 24.2 17.3 1.40 (0.84-2.33) 2.07 (1.25-3.46)
Hearing loss 43.5 45.8 49.7 45.7 1.10 (0.76-1.59) 1.28 (0.86-1.91)
Peripheral vascular disease 6.1 7.8 6.2 6.7 1.30 (0.63-2.66) 1.01 (0.44-2.33)
1 IADL impaired at baseline 12.2 20.3 26.8 18.3 1.83 (1.11-3.02) 2.63 (1.58-4.38)
Age, y 73.3 ± 5.0 74.4 ± 5.2 75.1 ± 4.8 74.1 ± 5.1 .02 .001
Education, years of schooling 9.9 ± 3.7 9.6 ± 3.9 9.2 ± 3.8 9.6 ± 3.8 .41 .08
BMI 26.3 ± 4.3 26.1 ± 4.0 26.3 ± 4.5 26.2 ± 4.2 .59 .97
Pulse pressure, mm Hg 64.2 ± 16.8 66.9 ± 16.8 66.2 ± 15.3 65.5 ± 16.4 .09 .21
Abbreviations: ARWMC, age-related white matter change; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared);
IADL, Instrumental Activities of Daily Living.
*Data are given as percentage or mean ± SD.
†Data are given as odds ratio (95% confidence interval) or P value (analysis of variance). Boldface values are statistically significant (P.05).
(REPRINTED) ARCH INTERN MED/VOL 167, JAN 8, 2007 WWW.ARCHINTERNMED.COM
83
©2007 American Medical Association. All rights reserved.
 at BIBLIOTECA BIOMEDICA, on January 9, 2007 www.archinternmed.comDownloaded from 
in the last year, complaint of gait disturbance, urinary
problems, and visual problems were all more frequent
among patients with themost severe degree of ARWMCs
(Table1). Subjectswith 1 IADL activity impaired at base-
line were more prevalent in the moderate or severe
ARWMC groups compared with the mild group.
One year after entry, 131 (21.2%) of the 619 subjects
had progressed to a lower functional level; of the 506 per-
forming fully independently at baseline, 40 proved to be
impaired in 1 activity and 43 in 2 or more activities. Of
the 113 limited in 1 activity at baseline, 48 had become
dependent on others in 2 or more activities and 26 had
returned to normal functioning (Table 2). There was a
gradient in the risk of reaching the study end point (de-
pendence in2 IADL activities) across patientswithmild,
moderate, and severe ARWMCs: 9%, 15%, and 26%, re-
spectively, in the target LADIS population and 5%, 9%,
and 15%, respectively, among patients whowere fully in-
dependent at entry (Figure 2). After comparing the se-
vere with the mild ARWMC severity group and adjust-
ing for other possible predictors of disability (Table 3),
the risk of such transition was more than 2-fold higher
(OR, 2.38; 95% confidence interval [CI], 1.29-4.38) for
target LADIS Study patients and 3-fold higher (OR, 3.02;
95% CI, 1.34-6.78) for patients fully independent at en-
try (Table 3). Older age, visual impairment, and base-
line IADL status (1 vs 0 item altered) were the other in-
dependent predictors of transition in the first group of
patients; for patients fully independent at entry, this was
the case for age and visual impairment. There was no ef-
fect related to sex. The severity of ARWMCs also pre-
dicted significantly and independently the transition from
0 to 1 activity impaired (adjustedOR, 2.99; 95%CI, 1.26-
7.11; severe vsmild ARWMCs). Severity of ARWMCs in-
dependently predicted the mean±SD number of altered
IADL activities (0.45±1.24 in themild group; 0.74±1.60
in the moderate group; 1.33±2.17 in the severe group).
The activities that were most frequently limited among
patients who declinedwere housekeeping, shopping, and
mode of transportation (Figure 3). For comparison, the
activities that were limited among the subjects impaired
at baseline were mode of transportation (26%), ability
to handle finance (23%), housekeeping (18%), respon-
sibilities for ownmedication (12%), laundry (10%), shop-
ping (7%), food preparation (3%), and ability to use the
telephone (2%). After controlling for acute events oc-
curring during the 1 year after initial assessment, the
effect of ARWMC severity in predicting functional de-
cline remained significant (OR, 2.71; 95% CI, 1.37-
5.34; severe vs mild ARWMCs).
Differences in measures of cognitive or motor perfor-
mance and mood status at baseline were related to dif-
ferent degrees of ARWMCs. Differences were evenmore
Table 2. Patients by Instrumental Activities
of Daily Living Status at Baseline vs 1-Year Follow-up
Activities Limited at
1-y Follow-up, No.
Activities Limited at Baseline, No.
0 1 Total
0 423 26 449
1 40 39 79
1 43 48 91
Total 506 113 619
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Figure 2. Transition in disability according to the Instrumental Activities of
Daily Living scale6 at 1 year across the 3 age-related white matter change
severity groups. LADIS indicates LeukoAraiosis and DISability.
Table 3. Independent Predictors of 1-Year Transition
in IADL Status*
Variables in
the Final Model
Patients With 0 or 1
Activity Limited
at Entry
(n = 619)
Patients With
No Activity
Limited at Entry
(n = 506)
ARWMC Severity
Mild 1.00 1.00
Moderate 1.26 (0.67-2.37) 1.87 (0.83-4.21)
Severe 2.38 (1.29-4.38) 3.02 (1.34-6.78)
0 or 1 limited IADL activity
at baseline
6.58 (3.91-11.08) 1.11 (1.04-1.19)
Age, y 1.09 (1.03-1.15) 0.51 (0.26-0.99)
Visual impairment 1.98 (1.12-3.49) 2.70 (1.31-5.56)
Abbreviations: ARWMC, age-related white matter change; IADL,
Instrumental Activities of Daily Living.
*Multiple logistic regression, stepwise method. See Table 1 for variables
in the analysis. Boldface values are statistically significant (P.05).
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Figure 3. Type of activity changed after 1 year among patients with functional
decline according to the Instrumental Activities of Daily Living scale.6
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apparent at the 1-year follow-up (Table4). Similar trends
were shown by urinary dysfunction. Evaluating which
of these changes made the greatest contribution to loss
of independence in IADL activities, the greatest modifi-
cation of the prediction of global functional decline by
ARWMC severity followed the introduction of the ADAS
or the SPPB score changes in the regression model
(Table 5). This indicates that, among selective func-
tions, impairments occurring in the motor and cogni-
tive domains best explained the effect of ARWMC sever-
ity on global functional decline.
COMMENT
The LADIS Study shows that elderly people, in whom ex-
tensive ARWMCs are discovered by brain imaging while
being investigated for nondisabling complaints, are at high
risk of declining in global functioning in a period as short
as 1 year. Among our patients, ARWMC severity pre-
dicted this decline independent of age and of several other
factors known to be associated with disability in the
elderly. The risk of decline increased with an increasing
degree of ARWMC severity, with an apparent dose ef-
fect. Also, ARWMC severity predicted independently the
number of instrumental activities that were limited af-
ter 1 year. The decline occurred mainly through motor
and cognitive deterioration.
Some factors may limit our conclusions. The LADIS
Study sample is not population based, and, although
nondisabled, the majority of subjects were enrolled
because they had sought medical attention for symp-
toms possibly related to ARWMCs. Therefore, in com-
parison with subjects with ARWMCs who are still free
of symptoms, the underlying disease process could have
been at baseline in a more advanced stage. The reasons
for referral were those commonly leading to discovery
of ARWMCs in elderly persons, and thus the LADIS
Study sample simply reflects the patient population
with ARWMCs that is likely to be encountered in clini-
cal practice. We included subjects with 1 IADL activity
limited to reflect the classification strategy adopted by
other longitudinal population-based studies on aging.
In our study, compared with people performing fully
independently in the IADL activities, patients with 1
IADL activity limited at baseline turned out to be more
prevalent in the group with severe ARWMCs at entry
and more prone to progress to a lower functional level.
However, the presence of these subjects in the analysis
did not alter the effect of ARWMC severity as an inde-
pendent determinant of functional decline. Such an
effect was equally apparent when considering the tran-
sition among subjects who were independent in any
IADL activity at entry.
Recent longitudinal studies15,16 have shown the dy-
namic nature of the disability process occurring at older
ageswhenprogressions in functional dependenceover time
may alternate with improvements. Indeed, in our study a
Table 5. Modification by Selective Functional Changes
of the Prediction by ARWMC Severity of Global Decline*
Variable
Effect on Transition,
OR (95% CI)†
ARWMC severity (severe vs mild) (unadjusted) 3.47 (2.00-6.02)
Adjusted for age 3.12 (1.79-5.46)
Adjusted for age plus:
SPPB 2.49 (1.30-4.74)
Urinary dysfunction 3.00 (1.71-5.27)
GDS 3.25 (1.80-5.86)
ADAS-Cog 2.58 (1.42-4.68)
Urinary dysfunctionGDS 3.09 (1.70-5.60)
Urinary dysfunctionSPPB 2.37 (1.23-4.54)
Urinary dysfunctionADAS-Cog 2.44 (1.34-4.45)
GDSSPPB 2.69 (1.39-5.24)
GDSADAS-Cog 2.81 (1.53-5.18)
SPPBADAS-Cog 2.25 (1.16-4.36)
SPPBADAS-CogGDSurinary dysfunction 2.22 (1.12-4.43)
Abbreviations: ADAS-Cog, Alzheimer Disease Assessment Scale–Cognitive
Subscale; ARWMC, age-related white matter change; CI, confidence interval;
GDS, Geriatric Depression Scale; OR, odds ratio; SPPB, Short Physical
Performance Battery.
*Target LADIS (LeukoAraiosis and DISability) Study population (619
patients).
†P.05 for all.
Table 4. Baseline, 1-Year Follow-up, and Differences of SPPB, ADAS-Cog, and GDS Scores, According to ARWMC Severity Degree*
Scale
ARWMC Severity
Total
P Value
(ANOVA)Mild Moderate Severe
SPPB
Baseline 10.3 ± 2.0 10.0 ± 2.0 9.2 ± 2.4 9.9 ± 2.1 .001
1-y Follow-up 10.0 ± 2.2 9.5 ± 2.6 8.5 ± 2.9 9.5 ± 2.6 .001
Difference 0.3 ± 1.7 0.5 ± 2.2 0.7 ± 2.1 0.5 ± 1.9 .22
ADAS-Cog
Baseline 15.2 ± 5.9 16.8 ± 7.5 18.1 ± 8.6 16.4 ± 7.2 .001
1-y Follow-up 15.5 ± 6.7 16.6 ± 7.4 20.0 ± 10.0 16.9 ± 8.0 .001
Difference 0.3 ± 5.0 0.2 ± 6.1 2.0 ± 6.5 0.5 ± 5.8 .003
GDS
Baseline 2.8 ± 2.9 3.1 ± 3.0 3.7 ± 3.5 3.1 ± 3.0 .03
1-y Follow-up 2.6 ± 2.9 3.0 ± 2.8 3.5 ± 3.1 2.9 ± 2.9 .03
Difference 0.2 ± 2.3 0.1 ± 2.4 0.2 ± 2.6 0.2 ± 2.4 .92
Abbreviations: ADAS-Cog, Alzheimer Disease Assessment Scale–Cognitive Subscale; ANOVA, analysis of variance; ARWMC, age-related white matter change;
GDS, Geriatric Depression Scale; SPPB, Short Physical Performance Battery.
*Data are given as mean±SD score unless otherwise specified.
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limited number of patients recovered to a better func-
tional status after 1 year. Intercurrent reversible events, in-
cluding acute diseases, hospitalizations, or changes in the
psychosocial situation, are themost common causes of re-
versible transitions.16,17 We were able to control for some
of these events: comparedwith subjectswhoremained func-
tionally unchanged, 1-year variation in living conditions,
falls, incident stroke or myocardial infarction, heart fail-
ure, or hospitalization were all more frequent among sub-
jects who had functional decline. However, after adjust-
ing for these events, the effect of ARWMC severity in
predicting functional decline remained significant.
We used the IADL scale as the tool for measuring dis-
ability as in previous studies. Reliability and validity of
such a scale is considered sufficient to warrant its use in
clinical situations.18 Compared with the Basic Activities
of Daily Living scale, the IADL scale may be more sen-
sitive to change in disability status occurring over short
periods in highly functioning or in mildly impaired sub-
jects.19,20 The IADL scale data may be subjected to vari-
ability depending on sociodemographic factors.19 Our as-
sessment of IADL proved to be consistent across several
sociocultural settings.
Disability in activities of daily living is common among
elderly persons and is associated with adverse outcomes
and high health care costs. According to the conceptual
model for the disablement process proposed by Nagi,21
active organ pathologic processes or disease leads to ana-
tomical, physiological, mental, or emotional impair-
ment, loss, or abnormalities, which in turn lead to func-
tional limitations resulting in disability. Disease processes
involving various organs may give rise to the chain of
events leading to functional dependence in elderly per-
sons. Up to now, clinical and epidemiological research
has focused predominantly on demographic, lifestyle, or
psychosocial factors of disability. Organ abnormalities in-
volved in the process of disability in the elderly popula-
tion are still incompletely understood, particularly as far
as the central nervous system is concerned. Modern im-
aging techniques may play a key role in disclosingmark-
ers of brain pathologic processes that possibly deter-
mine functional dependence in elderly persons.
Concerning neurological impairments underpinning dis-
ability, a substantial proportion of elderly adultsmay have
walking difficulty or cognitive impairment. Gait abnor-
malities are a common cause of falls, and slow gait pre-
dicts future functional decline22 and dementia.23 Cogni-
tive impairment without dementia affects 10% of people
older than 65 years.24 Over 10% of aged people have de-
pression.25 Urinary complaints are common in elderly
people, and sphincteric problems contribute to disabil-
ity in elderly people.26 All these conditions have been re-
ported consistently by many retrospective studies to be
associated with ARWMCs (for review see Kuo and Lip-
sitz3). Longitudinal data have recently confirmed that
ARWMCs predict motor performance decline,27 the on-
set of dementia,28 or deterioration in selective cognitive
domains.29 To our knowledge, no study has hitherto ad-
dressed whether, and to what extent, ARWMCs contrib-
ute to functional dependence in older adults. Answer-
ing this question may shed further light on pathological
mechanisms of disability, as well as on potential inter-
ventions for preventing or slowing such a process. On
the other hand, a recent study showed that white matter
changes detected by computed tomography were not as-
sociated with an increased risk of mortality when clini-
cal factors were taken into account.30Whether this is also
the case with respect to global functioning remains to be
determined.
In our 1-year follow-up, the LADIS Study has con-
firmed the hypothesis that ARWMCs affect global func-
tioning in elderly adults independently of and more
strongly than many other potential determinants of dis-
ability, acting mainly through deterioration of both cog-
nitive andmotor function. BecauseARWMCs are amarker
of small vessel disease associated with arterial hyperten-
sion and other vascular risk factors, our observationmay
be relevant for preventive strategies. Recent observa-
tions suggest that, for example, treating hypertensionmay
slow the progression of ARWMCs.31
Given the high frequency of ARWMCs among older
people, and considering that loss of independence in ev-
ery day life is an event crucial to the personal and social
life of older people, these results might be relevant to the
main functional problems related to aging.
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